Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|May 1, 2014

BioPharm International

  • BioPharm International-05-01-2014
  • Volume 27
  • Issue 5

Clinical Syringe Packages Increase Productivity

Clinical Syringe Packages Increase Productivity

Vetter introduces two clinical syringe packages that can start syringe development earlier in the drug development process, potentially cutting up to 18 months off time-to-market. Vetter’s Clinical Syringe Standard Package includes all development activities through launch, while the Clinical Syringe Starter Package offers a range of testing without the financial commitment to a clinical fill.

The standard package is an inclusive service, starting with the materials selection, which is a combination of syringe, needle, and stopper to meet a compound’s requirements and continuing through cGMP clinical syringe filling. The starter package begins with the same materials selection, proceeds through feasibility testing and regulatory consultation, and ends with a non-cGMP stability run.

According to the company, these packages may make it easier to recruit medical clinics for trials that use prefilled syringes, since they require less handling and preparation than vials and have reduced risk of needle-sticks.

Vetter


Related to this article

The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.